Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis

20 Mar 2020

Abstract excerpt

BACKGROUND: Upregulation of the six-transmembrane epithelial antigen of prostate-1 (STEAP1) is closely associated with prognosis of numerous malignant cancers. However, its role in lung adenocarcinoma (LUAD), the most common type of lung cancer, remains unknown. This study aimed to investigate the role of STEAP1 in the occurrence and progression of LUAD and the potential mechanisms underlying its regulatory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HER2/EGFR in Cancer Research
Share to Immunotherapy and Immune Responses
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32265985
DOI: 10.3389/fgene.2020.00242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic AnalysisPMID 32265985Read ↗

Expression and Prognostic Analyses of the Significance of STEAP1and STEAP2 in Lung CancerSemantic proximity Read ↗

The Role of PITPNC1 in Lung Adenocarcinoma: Differential Expression, Immune Infiltration, and Prognostic SignificanceSemantic proximity Read ↗

NUSAP1 is a Prognostic Biomarker and Correlated to Immune Infiltration in Lung AdenocarcinomaSemantic proximity Read ↗

Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinomaSemantic proximity Read ↗

Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinomaSemantic proximity Read ↗

Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validationSemantic proximity Read ↗

Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma.Semantic proximity Read ↗

Comprehensive analysis of prognostic value and immunological implication of YKT6 in lung adenocarcinomaSemantic proximity Read ↗

Identification of small proline‐rich protein 1B ( SPRR1B ) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysisSemantic proximity Read ↗

Twenty-gene-based prognostic model predicts lung adenocarcinoma survivalSemantic proximity Read ↗

Prognostic Implications and Immune Infiltration Analysis of SSBP1 in Lung AdenocarcinomaSemantic proximity Read ↗

Identification and Validation of a Proliferation-Associated Score Model Predicting Survival in Lung Adenocarcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.